Literature DB >> 33369277

The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers.

Chidera C Chukwueke1,2, William J Kowalczyk3,4, Marie Gendy1,2, Richard Taylor3, Rachel F Tyndale2,5,6, Bernard Le Foll1,2,5,6,7,8,9,10, Stephen J Heishman3.   

Abstract

INTRODUCTION: The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse-like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter CB1R expression, and be involved in nicotine dependence. To date, no study has explored the relationship between this SNP in CB1R and specific phenotypes of nicotine dependence.
METHODS: The current study investigated the influence of CB1R rs2023239 in nicotine reinforcement and craving in regular cigarette smokers. Current smokers (n = 104, cigarettes per day ≥ 10) were genetically grouped (C allele group vs. No C allele group) and underwent laboratory measures of nicotine reinforcement and smoking cue-elicited craving. Nicotine reinforcement was assessed using a forced choice paradigm, while a cue-reactivity procedure measured cue-elicited craving.
RESULTS: These results show that smokers with the C allele variant (CC + CT genotypes) experienced a lower nicotine reinforcement effect compared to those without the C allele (TT genotype). These results were similar in both our subjective and behavioral reinforcement measures, though the subjective effects did not withstand controlling for race. There was no difference between genotype groups with respect to cue-elicited craving, suggesting a lack of influence in cue reactivity.
CONCLUSION: Taken together, these results suggest that the variation in the CB1R (i.e., rs2023239 SNP) may play a larger role in nicotine reinforcement compared to cue reactivity. This work provides impetus to further understand the physiological mechanisms that explain how CB1Rs influence nicotine dependence phenotypes.
© 2020 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Entities:  

Keywords:  CB1R; genotype; nicotine cue reactivity; nicotine dependence; nicotine reinforcement

Mesh:

Substances:

Year:  2020        PMID: 33369277      PMCID: PMC7882168          DOI: 10.1002/brb3.1982

Source DB:  PubMed          Journal:  Brain Behav            Impact factor:   3.405


  32 in total

1.  The 2014 Surgeon General's report: "The health consequences of smoking--50 years of progress": a paradigm shift in cancer care.

Authors:  Graham W Warren; Anthony J Alberg; Andrew S Kraft; K Michael Cummings
Journal:  Cancer       Date:  2014-03-28       Impact factor: 6.860

2.  The independence of positive and negative affect.

Authors:  E Diener; R A Emmons
Journal:  J Pers Soc Psychol       Date:  1984-11

3.  Quitting Smoking Among Adults - United States, 2000-2015.

Authors:  Stephen Babb; Ann Malarcher; Gillian Schauer; Kat Asman; Ahmed Jamal
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-06       Impact factor: 17.586

4.  Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

Authors:  Caroline Cohen; Ghislaine Perrault; Guy Griebel; Philippe Soubrié
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

5.  Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).

Authors:  L Diergaarde; W de Vries; H Raasø; A N M Schoffelmeer; T J De Vries
Journal:  Neuropharmacology       Date:  2008-06-07       Impact factor: 5.250

6.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.

Authors:  Heather M Haughey; Erin Marshall; Joseph P Schacht; Ashleigh Louis; Kent E Hutchison
Journal:  Addiction       Date:  2008-08-14       Impact factor: 6.526

7.  Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.

Authors:  P-W Zhang; H Ishiguro; T Ohtsuki; J Hess; F Carillo; D Walther; E S Onaivi; T Arinami; G R Uhl
Journal:  Mol Psychiatry       Date:  2004-10       Impact factor: 15.992

8.  Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.

Authors:  Benoit Forget; Kathleen M Coen; Bernard Le Foll
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

9.  SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.

Authors:  C Cohen; G Perrault; C Voltz; R Steinberg; P Soubrié
Journal:  Behav Pharmacol       Date:  2002-09       Impact factor: 2.293

10.  Baclofen-induced Changes in the Resting Brain Modulate Smoking Cue Reactivity: A Double-blind Placebo-controlled Functional Magnetic Resonance Imaging Study in Cigarette Smokers.

Authors:  Ariel Ketcherside; Kanchana Jagannathan; Sudipto Dolui; Nathan Hager; Nathaniel Spilka; Chaela Nutor; Hengyi Rao; Teresa Franklin; Reagan Wetherill
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

View more
  4 in total

Review 1.  Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.

Authors:  Daniela Navarro; Ani Gasparyan; Francisco Navarrete; Abraham B Torregrosa; Gabriel Rubio; Marta Marín-Mayor; Gabriela B Acosta; Maria Salud Garcia-Gutiérrez; Jorge Manzanares
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 2.  Tobacco and nicotine use.

Authors:  Bernard Le Foll; Megan E Piper; Christie D Fowler; Serena Tonstad; Laura Bierut; Lin Lu; Prabhat Jha; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2022-03-24       Impact factor: 52.329

3.  The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers.

Authors:  Chidera C Chukwueke; William J Kowalczyk; Marie Gendy; Richard Taylor; Rachel F Tyndale; Bernard Le Foll; Stephen J Heishman
Journal:  Brain Behav       Date:  2020-12-25       Impact factor: 3.405

Review 4.  Biomarkers of the Endocannabinoid System in Substance Use Disorders.

Authors:  Francisco Navarrete; María S García-Gutiérrez; Ani Gasparyan; Daniela Navarro; Francisco López-Picón; Álvaro Morcuende; Teresa Femenía; Jorge Manzanares
Journal:  Biomolecules       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.